Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cerus Corporation    CERS

CERUS CORPORATION (CERS)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2018 04/16/2018 04/17/2018 04/18/2018 04/19/2018 Date
5.38(c) 5.35(c) 5.47(c) 5.64(c) 5.66(c) Last
427 091 489 544 687 941 1 022 317 585 326 Volume
-0.92% -0.56% +2.24% +3.11% +0.35% Change
More quotes
Financials (USD)
Sales 2018 67,9 M
EBIT 2018 -51,3 M
Net income 2018 -56,5 M
Finance 2018 43,7 M
Yield 2018 -
Sales 2019 102 M
EBIT 2019 -39,8 M
Net income 2019 -45,0 M
Finance 2019 13,7 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 10,1x
EV / Sales2019 7,01x
Capitalization 731 M
More Financials
Company
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products.It produces blood system for platelets and plasma.It markets its products under the INTERCEPT brand.The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is... 
More about the company
Surperformance© ratings of Cerus Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CERUS CORPORATION
04/12CERUS ENERGY : Announces $2 million Non-Brokered Private Placement
AQ
04/02CERUS : rsquo; RedeS Phase 3 Red Blood Cell Study Expands Into the Continental U..
BU
03/29CERUS : NKF Brings Two Tenants Totaling 70,000 Square Feet of Space to 1200 Conc..
AQ
03/26CERUS ENERGY : subsidiary 'TexAlta' Purchases Private Equity Company focusing on..
AQ
03/26CERUS ENERGY : subsidiary 'Camarico Group' launches new website and social media..
AQ
03/22CERUS : Announces the Fourth Biologics License Application BLA Approval for a U...
AQ
03/22CERUS CORPORATION : Cerus Corporation, Shares Up 39% in the Past Month, Analysts..
AC
03/16FRIDAY 3/16 INSIDER BUYING REPORT : Cers, qsii
AQ
03/15CERUS : to Present at the Cowen and Company 38th Annual Health Care Conference o..
AQ
03/13CERUS : Announces the Fourth Biologics License Application (BLA) Approval for a ..
BU
More news
Sector news : Medical Devices & Implants
04/19China May Request Minor Restrictions for Essilor Merger, Says Luxottica Chair..
DJ
04/19LUXOTTICA : chairman says China may seek 'minor restrictions' to clear Essilor d..
RE
04/04Smith & Nephew picks new CEO who sold his last company
RE
03/12Sensirion, Medartis to raise cash in Swiss IPO boom
RE
03/12STRAUMANN : Medartis to use IPO proceeds to expand amid rising implant demand
RE
More sector news : Medical Devices & Implants
Latest Tweets
04/17Cerus $CERS Lowered to “Hold” at Zacks Investment Research  
04/15Tyronn Lue says Rodney Hood will start at SG for Game 1. Starting Lineup: G..
8
04/15$CERS - Cerus #CERS Rating Lowered to Hold at Zacks Investment Research  
04/14The Warriors were determined to pick up their defense with the playoffs start..
1
04/13Cerus Co. $CERS Shares Bought by BlackRock Inc.  
More tweets
Qtime:256
News from SeekingAlpha
04/08WEEK 15 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
03/31WEEK 14 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
03/24WEEK 13 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
03/18WEEK 12 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
03/08Cerus' (CERS) CEO Obi Greenman on Q4 2017 Results - Earnings Call Transcript 
Chart CERUS CORPORATION
Duration : Period :
Cerus Corporation Technical Analysis Chart | CERS | US1570851014 | 4-Traders
Technical analysis trends CERUS CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 6,75 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
William Mariner Greenman President, Chief Executive Officer & Director
Daniel N. Swisher Chairman
Suzanne Margerum Vice President-Manufacturing & Operations
Kevin Dennis Green Chief Financial Officer & Vice President-Finance
Laurence M. Corash Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
CERUS CORPORATION61.83%731
STRYKER CORPORATION5.69%61 455
SMITH & NEPHEW4.04%16 747
JAPAN LIFELINE CO., LTD.25.88%2 489
WRIGHT MEDICAL GROUP NV-8.74%2 122
GLAUKOS CORP15.79%1 032